For Journalists

Main Menu

Content Type

ReleaseWire Mediawire

ReleaseWire Mediawire, a service provided to customers of ReleaseWire Newswire, allows businesses and non-profit organizations to distribute photos, videos, audio and documents. Please review copyright and usage information for each individual asset before using the asset in your publication or web site.

Caption: CEL-SCI Corporation (NYSE MKT: CVM) today announced that it has signed a co-development and profit sharing agreement with Ergomed Clinical Research Ltd. for CEL-SCI’s investigational immunotherapy drug Multikine (“Leucocyte Interleukin In